propylene glycol has been researched along with Motion Sickness in 1 studies
Propylene Glycol: A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.
propane-1,2-diol : The simplest member of the class of propane-1,2-diols, consisting of propane in which a hydrogen at position 1 and a hydrogen at position 2 are substituted by hydroxy groups. A colourless, viscous, hygroscopic, low-melting (-59degreeC) and high-boiling (188degreeC) liquid with low toxicity, it is used as a solvent, emulsifying agent, and antifreeze.
Motion Sickness: Disorder caused by motion. It includes sea sickness, train sickness, roller coaster rides, rocking chair, hammock swing, car sickness, air sickness, or SPACE MOTION SICKNESS. Symptoms include nausea, vomiting and/or dizziness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Development of dimenhydrinate (DMN) emulgel formulation has been described in this work with enhanced permeation for transdermal delivery of DMN for effective management of motion sickness." | 4.02 | Formulation and optimization of dimenhydrinate emulgels for topical delivery using response surface methodology. ( Arshad, MS; Hussain, T; Khalil, R; Khan, Q; Rizvi, SA; Shah, SNH; Shahzad, Y; Siddiqui, FA; Ul-Haq, Z; Usman, F; Yousaf, AM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, Q | 1 |
| Shah, SNH | 1 |
| Arshad, MS | 1 |
| Usman, F | 1 |
| Khalil, R | 1 |
| Ul-Haq, Z | 1 |
| Siddiqui, FA | 1 |
| Hussain, T | 1 |
| Yousaf, AM | 1 |
| Rizvi, SA | 1 |
| Shahzad, Y | 1 |
1 other study available for propylene glycol and Motion Sickness
| Article | Year |
|---|---|
Formulation and optimization of dimenhydrinate emulgels for topical delivery using response surface methodology.
Topics: Administration, Cutaneous; Animals; Antiemetics; Dimenhydrinate; Drug Delivery Systems; Emulsions; G | 2021 |